Filing Flows › America Great Health (AAGH) › Q2 FY26
America Great Health (AAGH) Q2 FY26 earnings results (second quarter fiscal 2026)
10-Q filed Jun 22, 2026
America Great Health (AAGH) reported revenue of $45K for the second quarter fiscal 2026 (Q2 FY26), -50% from a year earlier and -76% from the quarter before. Operating margin was -440.7%.
America Great Health, Q2 FY26: revenue $45K (-50% year over year), operating margin -440.7%, net earnings $1.1M, operating cash flow −$126K. The chart follows the revenue to costs, profit and cash.
| Q2 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $45K | -76% | -50% |
| Operating profit | −$199K | — | — |
| Net earnings | $1.1M | — | — |
| Operating cash flow | −$126K | -384% | -242% |
What changed
Revenue was $45K in Q2 FY26, down 50% year over year and down 76% from the previous quarter. Anti Aging Immune Support was the largest line at 59% of revenue. Anti Aging Immune Support lost $57K year over year (down 68%), 123% of the total change.
Gross margin was 81.0%, down 10.4 points from Q2 FY25. Operating costs exceeded revenue by $199K, an operating margin of -440.7%. Operating expenses grew 16% against a revenue fall of 50%. Net earnings were $1.1M. The effective tax rate was 0.0%. Non-operating items added $1.3M, 118% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$126K. Non-cash charges added back $4K of depreciation. Working capital and other items used $1.2M.
Questions
What was America Great Health's revenue in the second quarter fiscal 2026?
America Great Health (AAGH) reported revenue of $45K for the second quarter fiscal 2026 (Q2 FY26), -50% from a year earlier and -76% from the quarter before.
Was America Great Health profitable in the second quarter fiscal 2026?
Operating loss was $199K (-440.7% of revenue) and net earnings $1.1M.